Table 1. . Features of pharmacogenetic testing laboratories and summary of analysis of consent forms and test requisitions (n = 35).
N | Percentage | |
---|---|---|
Type of laboratory | ||
Reference laboratories (offers multiple tests) |
20 |
57% |
Laboratories offering PGx testing only† |
15 |
43% |
Commercial lab |
30 |
86% |
Academic lab |
5 |
14TT% |
Type of PGx test offered | ||
Offers single-gene PGx tests only |
8 |
23% |
Offers panel PGx tests |
17 |
49% |
Offers both single-gene and panel |
10 |
29% |
Laboratories with accessible informed consent |
22 |
63% |
Type of consent | ||
Patient-signed PGx-specific consent form |
3 |
14% |
Patient-signed general genetic testing consent form |
8 |
36% |
Patient-signed consent statement within requisition form |
4 |
18% |
Provider assent only required |
1 |
5% |
No consent/assent collected by lab |
6 |
27% |
Readability |
Average |
Range |
Word count (overall) |
568.2 |
68–1040 |
Word Count (patient consent embedded in test requisition) |
231.5 |
68–430 |
Word Count (patient consent as a separate form) |
680.4 |
363–1040 |
Flesch–Kincaid Reading Ease score (overall)‡ |
39.8 |
24–76.1 |
Flesch–Kincaid Reading Grade (overall)§ | 12.5 | 5.6–16.9 |
†Includes laboratories offering PGx and toxicology testing, but no other gene-based tests.
‡Calculated based on average number of syllables per word and words per sentence (0–100 scale; 0 = very difficult and 100 = very easy).
§Text ranked on a US grade-school level based on the average number of syllables per word and words per sentence.
PGx: Pharmacogenetic.